Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female at least 18 years of age who are scheduled for unilateral cataract surgery~Exclusion Criteria:~* Have known hypersensitivity to bromfenac or to any component of the investigational product

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bromfenac ophthalmic solution 0.09% (Type: EXPERIMENTAL): dosed 1 drop daily in study eye for 2 weeks
- Placebo (Type: PLACEBO_COMPARATOR): dosed 1 drop daily in study eye for 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).